SonoSim releases pediatric ultrasound training modules
January 13, 2020 -- Ultrasound education firm SonoSim has launched the first in a series of pediatric ultrasound training modules.
January 13, 2020 -- Ultrasound education firm SonoSim has launched the first in a series of pediatric ultrasound training modules.
Life Image, Univ. of Chicago partner on breast study
January 13, 2020 -- Medical image-sharing provider Life Image will provide its Mammosphere breast health data access tool to the University of Chicago to support a large-scale clinical trial for breast cancer screening.
January 13, 2020 -- Medical image-sharing provider Life Image will provide its Mammosphere breast health data access tool to the University of Chicago to support a large-scale clinical trial for breast cancer screening.
HealthLytix adds CT CoPilot to Nuance AI marketplace
January 13, 2020 -- Precision health technology developer HealthLytix said it will make its CT CoPilot artificial intelligence (AI) software for head CT exams available in the Nuance Communications' AI Marketplace for Diagnostic Imaging.
January 13, 2020 -- Precision health technology developer HealthLytix said it will make its CT CoPilot artificial intelligence (AI) software for head CT exams available in the Nuance Communications' AI Marketplace for Diagnostic Imaging.
UCI receives $1.2M to study AR use for medical training
January 13, 2020 -- The University of California, Irvine (UCI) School of Medicine has received $1.2 million to research the physiological and psychological effects of using augmented reality (AR) technology for medical simulation training.
January 13, 2020 -- The University of California, Irvine (UCI) School of Medicine has received $1.2 million to research the physiological and psychological effects of using augmented reality (AR) technology for medical simulation training.
FDA offers guidance on angioplasty and specialty catheters
January 10, 2020 -- The U.S. Food and Drug Administration (FDA) has issued a draft guidance for premarket submission applications of peripheral percutaneous transluminal angioplasty and specialty catheters.
January 10, 2020 -- The U.S. Food and Drug Administration (FDA) has issued a draft guidance for premarket submission applications of peripheral percutaneous transluminal angioplasty and specialty catheters.
Strategic Radiology, Mach7 partner on data exchange tool
January 10, 2020 -- Radiology consortium Strategic Radiology has partnered with data management firm Mach7 Technologies to allow its independent member groups to securely exchange clinical data using a new tool.
January 10, 2020 -- Radiology consortium Strategic Radiology has partnered with data management firm Mach7 Technologies to allow its independent member groups to securely exchange clinical data using a new tool.
Covera Health adds to coffers
January 10, 2020 -- Clinical analytics firm Covera Health has wrapped up a $23.5 million series B financing round led by Insight Partners.
January 10, 2020 -- Clinical analytics firm Covera Health has wrapped up a $23.5 million series B financing round led by Insight Partners.
Lunit nets $26M in new funding
January 10, 2020 -- Artificial intelligence image analysis software developer Lunit has received $26 million in a new funding round from Asian investors.
January 10, 2020 -- Artificial intelligence image analysis software developer Lunit has received $26 million in a new funding round from Asian investors.
DOE waives export ban on highly enriched uranium
January 9, 2020 -- The U.S. Department of Energy (DOE) is moving to allow the export of weapons-grade uranium, the same substance used to manufacture medical isotopes, such as molybdenum-99.
January 9, 2020 -- The U.S. Department of Energy (DOE) is moving to allow the export of weapons-grade uranium, the same substance used to manufacture medical isotopes, such as molybdenum-99.
Accuray touts CyberKnife study results
January 9, 2020 -- Radiation oncology firm Accuray is touting the results of a prospective study in which stereotactic body radiation therapy performed with its CyberKnife system provided excellent disease control at the five-year mark for men with locally recurrent prostate cancer.
January 9, 2020 -- Radiation oncology firm Accuray is touting the results of a prospective study in which stereotactic body radiation therapy performed with its CyberKnife system provided excellent disease control at the five-year mark for men with locally recurrent prostate cancer.